ProFoldBio

Private

Goleta, CaliforniaHealthcare & Life Scienceshttps://www.profoldbio.com/

Last Round

M&A

May 21, 2024

Est. Valuation

$1.8B

Total Funding Raised

$247M

Company Overview

ProFoldBio is a biotechnology company that provides a software platform using generative AI to accelerate the discovery and development of therapies for diseases such as Alzheimer's.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

protein stabilityprotein aggregationAI drug discoverydrug discovery platformsingle-molecule analysisgenerative biologybiologics developmentAI protein designAI-native biotechde-novo antibody designin-silico screeningcomputational drug discoverydrug discovery SaaSmonoclonal antibodiesformulation serviceslife sciences instrument

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProFoldBio Comps

Public and private peers based on sector, stage, and business model.

ProFoldBio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ProFoldBio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	May 21, 2024
Series B	Feb 13, 2024
Series A Extension	Jun 2, 2022
Series A	Jul 12, 2021

View all Funding Rounds

ProFoldBio Investors

Notable investors and investment history

ProFoldBio investors
Investor	Rounds
Surveyor Capital	Series B
Janus Henderson Group	Series B
RA Capital Management	Series B
LifeSci Venture Partners	Series B
Oriza Holdings	Series A Extension, Series A
Ally Bridge Group	Series B
LYFE Capital	Series A Extension, Series B, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 21, 2024
$1.8B round led by Genmab A/S
Feb 13, 2024
$112M round led by Ally Bridge Group.

View all signals

ProFoldBio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ProFoldBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ProFoldBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersGoleta, California

Year Founded2025

Last FundingMay 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.